Biotech Value Stocks Climb Out of Their Sick Bed

📆 03/11/2019 11.30.00
📰 WSJ

⏱ Reading Time:
17 sec. here
2 min. at publisher
📊 Quality Score:
News: 10%
Publisher: 63%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

Heard on the Street: Recent good news from Biogen and Bristol-Myers Squibb bolsters hope that years of weak performance may be ending

The biotechnology universe is divided into two groups.

The majority are companies without profits, or even sales, chasing a scientific breakthrough and the resulting massive payoff for investors. A much smaller group of companies have graduated to megacap status. Like most companies of their size, these sport massive profits and cash flows, with much less growth potential.

Tulis Komentar

No, you are correct🧡

I guess that could happen))😀

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Berkshire Hathaway’s Quarterly Earnings Fell as Unrealized Investment Gains DeclinedWarren Buffett’s Berkshire Hathaway said third-quarter earnings fell as unrealized investment gains declined but operating earnings climbed In other words...he made money. Bail! There are plenty of other choices. It's a pity, but no better idea.
Sumber: WSJ - 🏆 98. / 63 Baca lebih lajut »